AF
BBIO icon

Advisornet Financial’s BridgeBio Pharma BBIO Stock Holding History

Advisornet Financial’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$37.3K Buy
502
+32
+7% +$2.32K ﹤0.01% 1148
2025
Q4 		$36K Buy
470
+56
+14% +$3.68K ﹤0.01% 1161
2025
Q3 		$21.5K Buy
414
+51
+14% +$2.49K ﹤0.01% 1280
2025
Q2 		$15.7K Buy
363
+20
+6% +$727 ﹤0.01% 1353
2025
Q1 		$11.9K Buy
343
+336
+4,800% +$11.3K ﹤0.01% 1356
2024
Q4 		$192 Hold
7
– – ﹤0.01% 1883
2024
Q3 		$178 Buy
+7
New +$184 ﹤0.01% 2129
2024
Q1 		– Sell
-22
Closed -$888 – 2089
2023
Q4 		$888 Buy
22
+4
+22% +$120 ﹤0.01% 1915
2023
Q3 		$475 Buy
18
+6
+50% +$170 ﹤0.01% 1995
2023
Q2 		$206 Buy
12
+4
+50% +$60 ﹤0.01% 2215
2023
Q1 		$133 Buy
8
+1
+14% +$12 ﹤0.01% 2293
2022
Q4 		$53 Buy
+7
New +$67 ﹤0.01% 2328

Other funds holding BBIO

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $15.3B AUM 50.95% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return